PUBLISHER: The Business Research Company | PRODUCT CODE: 1939343
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939343
Bioengineered artificial skin is a lab-produced substitute designed to replicate the structure and function of natural human skin. It is created using living cells combined with synthetic or natural materials to imitate the skin's layers, mainly the epidermis and dermis. This artificial skin is employed in wound healing, burn care, skin grafting, and pharmaceutical or cosmetic testing. By encouraging cell proliferation and tissue regeneration, it provides an important option when the body's natural skin healing is inadequate or unavailable.
The primary types of bioengineered artificial skin include acellular dermal matrices, cell-based skin substitutes, skin grafts, and 3D bioprinted skin. Acellular dermal matrices (ADMs) are biological scaffolds sourced from human or animal skin, with all cellular material removed, leaving a structural framework composed of proteins such as collagen and elastin. The materials used include collagen-based, hyaluronic acid-based, silicone-based, and polyurethane-based types, while the technologies applied involve bioprinting, electrospinning, self-assembly, and microfabrication. These products find applications in burn treatment, chronic wound management, surgical reconstruction, and more, and are utilized by a range of end users including hospitals, dermatology clinics, ambulatory surgical centers, and research organizations.
Tariffs are impacting the bioengineered artificial skin market by increasing costs of imported biomaterials, cell culture reagents, bioprinting equipment, and laboratory-grade polymers used in skin substitute manufacturing. Research institutions and healthcare providers in North America and Europe are most affected due to reliance on imported high-value materials, while Asia-Pacific faces higher costs for export-oriented production. These tariffs are increasing development costs and slowing commercialization timelines. However, they are also encouraging domestic biomaterial production, localized bioprinting capabilities, and stronger regional regenerative medicine supply chains.
The bioengineered artificial skin market research report is one of a series of new reports from The Business Research Company that provides bioengineered artificial skin market statistics, including bioengineered artificial skin industry global market size, regional shares, competitors with a bioengineered artificial skin market share, detailed bioengineered artificial skin market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineered artificial skin industry. This bioengineered artificial skin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioengineered artificial skin market size has grown rapidly in recent years. It will grow from $2.73 billion in 2025 to $3.07 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to increasing incidence of burn injuries, rising prevalence of chronic wounds, expansion of reconstructive surgical procedures, advances in tissue engineering research, growing availability of biomaterial technologies.
The bioengineered artificial skin market size is expected to see rapid growth in the next few years. It will grow to $4.88 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing adoption of regenerative medicine therapies, rising demand for advanced wound care solutions, expansion of stem cell-based skin treatments, growing investments in bioprinting technologies, increasing focus on personalized regenerative healthcare. Major trends in the forecast period include increasing development of cell-based skin substitutes, rising adoption of 3D bioprinted skin constructs, growing use of biomimetic scaffold materials, expansion of regenerative wound healing applications, enhanced focus on personalized skin regeneration.
The rising demand for cosmetic and reconstructive surgery is expected to drive the growth of the bioengineered artificial skin market in the coming years. Cosmetic and reconstructive surgery encompasses medical procedures aimed at enhancing physical appearance or restoring the form and function of body parts affected by congenital conditions, trauma, or disease. This demand is increasing due to greater consumer awareness of aesthetic enhancement options and a growing need for medical restoration following trauma, congenital anomalies, or illness-related deformities. Bioengineered artificial skin supports these procedures by promoting tissue regeneration, minimizing scarring, and improving aesthetic outcomes in the restoration or enhancement of damaged or missing skin. For example, in January 2023, the International Society of Aesthetic Plastic Surgery, a U.S.-based professional organization dedicated to advancing aesthetic plastic surgery, reported that over 12.8 million surgical and 17.5 million non-surgical procedures were performed globally, representing a 19.3% increase in total procedures from the previous reporting period. Additionally, plastic surgeons worldwide conducted more than 14.9 million surgical and 18.8 million non-surgical procedures in 2022, marking an 11.2% increase in total procedures performed. Consequently, the growing demand for cosmetic and reconstructive surgery is driving the expansion of the bioengineered artificial skin market.
Key companies in the bioengineered artificial skin market are focusing on technological advancements, including sophisticated tissue engineering methods, to develop highly effective skin substitutes that promote wound healing, improve patient outcomes, and meet the growing demand for regenerative medicine in treating severe burns and chronic wounds. Advanced tissue engineering integrates biology, materials science, and engineering to produce synthetic or biologically derived tissues and organs that mimic the structure and function of natural tissues for medical use. For instance, in January 2023, Urgo Group, a France-based healthcare company, launched the Genesis research laboratory dedicated to developing artificial skin to support the effective treatment of severe wounds. This initiative aims to assist healthcare professionals by creating advanced bioengineered skin solutions that accelerate recovery and enhance wound-healing outcomes.
In August 2023, Coloplast A/S, a healthcare company based in Denmark, acquired Kerecis for an undisclosed sum. This acquisition is intended to expand Coloplast's presence in the advanced wound care market by incorporating Kerecis' innovative fish-skin-based regenerative technology. This strengthens Coloplast's position in biological wound care solutions and addresses the increasing global demand for effective wound healing therapies. Kerecis Limited, based in the US, produces bioengineered artificial skin substitutes derived from fish skin, specifically designed for wound healing and tissue regeneration.
Major companies operating in the bioengineered artificial skin market are Stryker Corporation, Smith & Nephew plc, Molnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Organogenesis Inc., MiMedx Group Inc., Vericel Corporation, AlloSource Inc., Kerecis Inc., PolyNovo Limited, Avita Medical Inc., Cook Biotech Incorporated, Tissue Regenix Group plc, Episkin SA, TissUse GmbH, RenovaCare Inc., PolarityTE Inc., Mallinckrodt Pharmaceuticals (Skin Substitutes), Medtronic plc (Regenerative Therapies), 3D Bioprinting Solutions
North America was the largest region in the bioengineered artificial skin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioengineered artificial skin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioengineered artificial skin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bioengineered artificial skin market consists of revenues earned by entities by providing services such as customization and design services, clinical trial and regulatory support services, and post-implantation monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioengineered artificial skin market also includes sales of integra dermal regeneration template, primatrix, pico system, and advanced wound care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioengineered Artificial Skin Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses bioengineered artificial skin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioengineered artificial skin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioengineered artificial skin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.